Selected Publications

Complete List can be found here: Google Scholar

  1. Burgess, A., Vuong, J., Rogers, S., Malumbres, M., and O’Donoghue, S. I. (2017) SnapShot: Phosphoregulation of Mitosis. Cell 169, 1358–1358.e1 [PDF Link][Interactive Website]
  2. Szczepny, A., Rogers, S., Jayasekara, W. S. N., Park, K., McCloy, R. A., Cochrane, C. R., Ganju, V., Cooper, W. A., Sage, J., Peacock, C. D., Cain, J. E., *Burgess, A., and *Watkins, D. N. (2017) The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer. Oncogene In Press *co-corresponding author [Link]
  3. Vennin, C. et al…. Burgess, A., Cox, T. R., Morton, J. P., Pajic, M., and Timpson, P. (2017) Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Science translational medicine. 9, 384 . [Link][Feature Article]
  4. Haupt, S., Vijayakumaran, R., Panimaya, J., Burgess, A., Lim, E., and Haupt, Y. (2017). The role of MDM2 and MDM4 in breast cancer development and prevention. Journal of molecular cell biology. 9, 1, 53–61. [Link]
  5. Gabrielli, B.G. and Burgess, A. (2016). Cdc25 Family Phosphatases in Cancer. Protein Tyrosine Phosphatases in Cancer. B.G. Neel and N.K. Tonks, eds. Springer New York. 283–306. [Link]
  6. Rogers, S., Fey, D., McCloy, RA., Parker, BL., Mitchell, NJ., Payne, RJ., Daly, RJ., James, DE., Caldon, CE., Watkins, DN., Croucher, DR., Burgess, A. (2016) PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells. J Cell Sci 129 (7), 1340-1354. [Link][Feature Article]
  7. Burgess, A., Chia, KM., Haupt, S., Thomas, D., Haupt, Y., Lim, E. (2016) Clinical overview of MDM2/X targeted therapies Frontiers in Oncology 6, 7 [Link]
  8. Rogers, S., McCloy, R., Watkins, D. N. and Burgess, A. (2016). Mechanisms regulating phosphatase specificity and the removal of individual phosphorylation sites during mitotic exit. BioEssays.[Link]
  9. Rogers, S., McCloy, R. A., Parker, B. L., Chaudhuri, R., Gayevskiy, V., Hoffman, N. J., Watkins, D. N., Daly, R. J., James, D. E. and Burgess, A. (2015). Dataset from the global phosphoproteomic mapping of early mitotic exit in human cells. Data in Brief 5, 45–52.[Link]
  10. McCloy, R., Parker, B. L., Rogers, S., Chaudhuri, R., Gayevskiy, V., Hoffman, N. J., Ali, N., Watkins, D. N., Daly, R., James, D. E., Lorca, T., Castro, A., and Burgess, A. (2015) Global phosphoproteomic mapping of early mitotic exit in human cells identifies novel substrate dephosphorylation motifs. Molecular & Cellular Proteomics. 14, 2194–2212 (I.F = 7.25) [Link][F1000Prime RecommendedFront Cover 
  11. Burgess, A. (2015) Degrading Claspin away with Cdh1 and Cyclin A. Cell Cycle 14, 171–171 (I.F = 5.36) [Link].
  12. Rogers, S., Gloss, B. S., Lee, C. S., Sergio, C. M., Dinger, M. E., Musgrove, E. A., Burgess, A., and Caldon, C. E. (2015) Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells. Cell Division 10, 1 (I.F = 2.63) [Link].
  13. McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. (2014) Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events. Cell Cycle.  2014 Mar 6;13(9):0–12. [Link] Front Cover
  14. McCloy RA, Shelley EJ, Roberts CG, Boslem E, Biden TJ, Nicholson RI, Gee JM, Sutherland RL, Musgrove EA, Burgess A, and Butt A (2013) Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells.
    Br. J. Cancer 109: 3034–3041 [Link]
  15. Burgess, A., Lorca, T., Castro, A (2012). Quantitative Live Imaging of Endogenous DNA Replication in Mammalian Cells. PLoS ONE. 7(9): e45726. [Link]
  16. Wigan, M., Pinder, A., Giles, N., Pavey, S., Burgess, A., Wong, S., Sturm, R. A., et al. (2012). A UVR-Induced G2-Phase Checkpoint Response to ssDNA Gaps Produced by Replication Fork Bypass of Unrepaired Lesions Is Defective in Melanoma. The Journal of Investigative Dermatology. 132(6):p1681-8 [Link]
  17. Vigneron S, Gharbi-Ayachi A, Raymond A, Burgess A, Labbé J, Labesse G, Monsarrat B, Lorca T & Castro A (2011) Characterization of the mechanisms controlling greatwall activity. Mol. Cell. Biol. 31(11): p.2262-2275 [Link]
  18. Gharbi-Ayachi, A., Labbé, JC., Burgess, A., Vigneron, S., Strub, JM., Brioudes, E., Van-Dorsselaer, A., Castro A and Lorca, T (2010). The Substrate of Greatwall kinase, Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase PP2A. Science (330) p.1673-1677 [LinkF1000Prime Recommendation
  19. Burgess, A., Brioudes, E., Vigneron, S., Labbe, JC., Lorca, T and Castro, A (2010) Human Greatwall controls mitotic entry and progression by maintaining a correct Cdc2/PP2A balance. PNAS. 107(28): p.12564-12569 [Link]
  20. Lorca, T., Bernis, C., Vigneron, S., Burgess, A., Brioudes, E., Labbe, JC and Castro, A (2010). Constant regulation of the MPF amplification loop and the Greatwall/PP2A pathway is required for a correct first Embronic cell division. J. Cell. Science. 123 (13): p.2281-2291. [Link]
  21. Vigneron, S., Brioudes, E., Burgess, A., Labbe, Jc., Lorca, T And Castro, A (2009) Greatwall maintains mitosis through regulation of PP2AEMBO Journal. 28(18): p. 2786-2793. [Link]
  22. Burgess, A., Labbe, Jc., Vigneron, S., Bonneaud, N., Strub, Van Dorsselaer, A., Lorca, T And Castro, A (2008) Chfr interacts and colocalizes with TCTP to the mitotic spindle.Oncogene27(42): p. 5554-5566. [Link]
  23. Burgess, A., Wigan, M., Giles, N., Depinto, W., Gillespie, P., Stevens, F And Gabrielli, B (2006) Inhibition of S/G(2) phase CDK4 reduces mitotic fidelityJ. Bio. Chem281(15): p. 9987-9995. [Link]
  24. Wong, C.F., Guminski, A., Saunders, N And Burgess, A (2005) Exploiting novel cell cycle targets in the development of anticancer agentsCurrent Cancer Drug Targets. 5(2): p. 85-102. [Link]
  25. Burgess, A., Ruefli, A., Beamish, H., Warrener, R., Saunders, N., Johnstone, R And Gabrielli, B (2004) Histone deacetylase inhibitors specifically kill nonproliferating tumour cells. Oncogene. 23(40): p. 6693-6701. [Link]
  26. Burgess, A., Pavey, S., Warrener, R., Hunter, L., Piva, T., Musgrove, E., Saunders, N., Parsons, P And Gabrielli, B (2001) Up-regulation of p21(WAF1)/(CIP1) by histone deacetylase inhibitors reduces their cytotoxicityMol. Pharmacology60(4): p. 828-837. [Link]
  27. #Qiu, L., #Burgess, A, Fairlie, D., Leonard, H., Parsons, P And B. Gabrielli (2000) Histone Deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cellsMol. Biol. Cell. 11(6): p. 2069
    # Denotes equal first author. [Link]


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s